Ichiro Takada

6.2k total citations · 1 hit paper
50 papers, 3.8k citations indexed

About

Ichiro Takada is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ichiro Takada has authored 50 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in Ichiro Takada's work include Peroxisome Proliferator-Activated Receptors (13 papers), Bone Metabolism and Diseases (8 papers) and Cancer-related gene regulation (7 papers). Ichiro Takada is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (13 papers), Bone Metabolism and Diseases (8 papers) and Cancer-related gene regulation (7 papers). Ichiro Takada collaborates with scholars based in Japan, United States and France. Ichiro Takada's co-authors include Shigeaki Kato, Alexander Kouzmenko, Makoto Makishima, Akihiko Yoshimura, Hiroaki Ooboshi, Takashi Shichita, Yuki Sugiyama, Ryusuke Nakagawa, Yasunori Okada and J. Daniel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ichiro Takada

47 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury

2009 710 citations Takashi Shichita, Yuki Sugiyama et al. Nature Medicine profile →

Peers

Countries citing papers authored by Ichiro Takada

Since Specialization

Citations

This map shows the geographic impact of Ichiro Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Takada more than expected).

Fields of papers citing papers by Ichiro Takada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Takada. The network helps show where Ichiro Takada may publish in the future.

Co-authorship network of co-authors of Ichiro Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Takada. A scholar is included among the top collaborators of Ichiro Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Takada. Ichiro Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of ESS2/DGCR14: Is It an Essential Factor in Splicing and Transcription? 2025 ·International Journal of Molecular Sciences ·Ichiro Takada, Shinya Hidano, Tohru Nakagawa, Shinichi Nakagawa, Makoto Makishima, Sayuri Takahashi	0
2	Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells 2025 ·International Journal of Molecular Sciences ·Hiromi Yamaguchi, (unknown), Xian‐Yang Qin, Yuriko Abe, Ichiro Takada, (unknown), (unknown), Shigeyuki Uno, Makoto Makishima, Mariko Esumi	0
3	Dibenzolium induces apoptosis and inhibits epithelial-mesenchymal transition (EMT) in bladder cancer cell lines 2024 ·Scientific Reports ·(unknown), Jack L. Arbiser, (unknown), (unknown), (unknown), Ichiro Takada, Kuan‐Chou Chen, Shian‐Ying Sung, Katsumi Shigemura	1
4	Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators 2023 ·Asian Journal of Andrology ·Sayuri Takahashi, Ichiro Takada	4
5	ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1 2023 ·Scientific Reports ·Sayuri Takahashi, Ichiro Takada, Kenichi Hashimoto, Atsushi Yokoyama, Tohru Nakagawa, Makoto Makishima, Haruki Kume	4
6	Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways 2022 ·Journal of Biological Chemistry ·Ichiro Takada, Shinya Hidano, Sayuri Takahashi, Kaori Yanaka, Hidesato Ogawa, Megumi Tsuchiya, Atsushi Yokoyama, Shingo Sato, Hiroki Ochi, Tohru Nakagawa, Takashi Kobayashi, Shinichi Nakagawa, Makoto Makishima	10
7	Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains 2018 ·Biochemical and Biophysical Research Communications ·Ichiro Takada, Megumi Tsuchiya, Kaori Yanaka, Shinya Hidano, Sayuri Takahashi, Takashi Kobayashi, Hidesato Ogawa, Shinichi Nakagawa, Makoto Makishima	12
8	Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells 2018 ·International Journal of Molecular Sciences ·Masahiko Kainuma, Ichiro Takada, Makoto Makishima, Keiji Sano	36
9	Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands 2016 ·Current Medicinal Chemistry ·Ichiro Takada, Makoto Makishima	16
10	Therapeutic application of vitamin D receptor ligands: an updated patent review 2015 ·Expert Opinion on Therapeutic Patents ·Ichiro Takada, Makoto Makishima	14
11	Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways 2012 ·International Immunology ·Yuki Sugiyama, (unknown), Akihiro Kimura, Ichiro Takada, Ikko Kashiwagi, Y Wakabayashi, Rimpei Morita, Masatoshi Nomura, Akihiko Yoshimura	43
12	Identification of Osteoclastic Factors in the Nuclear Envelope of Mature, Multinucleated Osteoclasts 2010 ·Bioscience Biotechnology and Biochemistry ·(unknown), Sally Fujiyama‐Nakamura, Ichiro Takada, Yuuki Imai, Shigeaki Kato	3
13	Purification and identification of estrogen receptor alpha co‐regulators in osteoclasts 2010 ·Annals of the New York Academy of Sciences ·Ichiro Takada, (unknown), (unknown), Sally Fujiyama, M. Okada, Yuuki Imai, (unknown), (unknown), Hisataka Yasuda, Shigeaki Kato	3
14	SOCS3 in T and NKT Cells Negatively Regulates Cytokine Production and Ameliorates ConA-Induced Hepatitis 2009 ·The Journal of Immunology ·Mako Nakaya, Masayuki Hashimoto, Ryusuke Nakagawa, Yu Wakabayashi, Takuma Ishizaki, Ichiro Takada, Kyoko Komai, Hiroki Yoshida, Akihiko Yoshimura	37
15	Estrogens Maintain Bone Mass by Regulating Expression of Genes Controlling Function and Life Span in Mature Osteoclasts 2009 ·Annals of the New York Academy of Sciences ·Yuuki Imai, (unknown), Shino Kondoh, Takashi Nakamura, Alexander Kouzmenko, Takahiro Μatsumoto, Ichiro Takada, Kunio Takaoka, Shigeaki Kato	77
16	Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis 2009 ·Nature Reviews Rheumatology ·Ichiro Takada, Alexander Kouzmenko, Shigeaki Kato	425
17	Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury breakdown → 2009 ·Nature Medicine ·Takashi Shichita, Yuki Sugiyama, Hiroaki Ooboshi, Hiroshi Sugimori, Ryusuke Nakagawa, Ichiro Takada, Toru Iwaki, Yasunori Okada, Mitsuo Iida, J. Daniel, Yoichiro Iwakura, Akihiko Yoshimura	710
18	[Molecular mechanism of switching adipocyte / osteoblast differentiation through regulation of PPAR-gamma function]. 2008 ·PubMed ·Ichiro Takada, Shigeaki Kato	8
19	Dioxin receptor is a ligand-dependent E3 ubiquitin ligase 2007 ·Nature ·Fumiaki Ohtake, Atsushi Baba, Ichiro Takada, M. Okada, (unknown), Hiromi Miki, Sayuri Takahashi, Alexander Kouzmenko, Keiko Nohara, Tomoki Chiba, Yoshiaki Fujii‐Kuriyama, Shigeaki Kato	452
20	Premature ovarian failure in androgen receptor-deficient mice 2005 ·Proceedings of the National Academy of Sciences ·Hiroko Shiina, Takahiro Μatsumoto, Takashi Sato, Katsuhide Igarashi, Junko Miyamoto, (unknown), Matomo Sakari, Ichiro Takada, Takashi Nakamura, Daniel Metzger, Pierre Chambon, Jun Kanno, Hiroyuki Yoshikawa, Shigeaki Kato	255

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact